Skip to Content

Koninklijke Philips NV ADR PHG Stock Quote

| Rating as of


Morningstar‘s Stock Analysis PHG

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Reducing Our Philips FVE to EUR 25; We Expect a Weak 2022 and 2023

Javier Correonero Equity Analyst

Business Strategy and Outlook

| Javier Correonero |

Philips is a one-stop shop for imaging-related devices with an established footprint in many hospitals, which positions it to benefit from long-term healthcare trends like the transition to non- or minimally invasive procedures, increased hospital demand for efficiencies, or detection of sleep apnea. Through several divestitures and acquisitions, Philips has transformed itself from an industrial-medical conglomerate into a healthcare company and primary supplier across hospitals, which facilitates the introduction of new products and the displacement of smaller suppliers with more depth in a single product line but lack of breadth. In many of its underlying markets, the company operates an oligopoly where significant market share is controlled by a few players. Several of the company’s products require proprietary software or service, which provide stability to cash flows and help to lock in the customer. In addition, the company has carried out several divestments and acquisitions, which we believe has reinforced its positioning. The company continues to narrow its business focus, selling its domestic appliances business in 2021.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics PHG

Company Profile PHG

Business Description

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Philips Center, Amstelplein 2
Amsterdam, 1096 BC, NLD
Industry Medical Devices
Employees 79,097

Related Articles PHG

FAQs for Koninklijke Philips NV ADR Stock

Yes. PHG has a forward dividend yield of 6.42%. See PHG’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

PHG’s market cap is 12.61 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

PHG’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

PHG’s price/sales is 0.69.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

PHG’s price/forward earnings is 14.71.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

PHG’s price/book is 0.81.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See PHG’s valuation ratios compared to the Market Index.

PHG’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare PHG’s historical performance against its industry peers and the overall market.